Gastric cancer in a Caucasian population: Role of pepsinogen C genetic variants

World Journal of Gastroenterology

Volumn 12, Issue 31, 2006, Pages 5033-5036

  Pinto Correia, Ana L ^a   Sousa, Hugo ^a   Fragoso, Maria ^a   Moreira Dias, Luís ^a   Lopes, Carlos ^a,b   Medeiros, Rui ^a,b   Dinis Ribeiro, Mário ^a,c  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c University of Porto   (Portugal)

Author keywords

Gastric adenocarcinoma; Pepsinogen C; Polymorphism

Indexed keywords

PEPSINOGEN II;

ALLELE; ARTICLE; ASIAN; ATROPHY; CANCER INVASION; CAUCASIAN; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE INSERTION; GENETIC DIFFERENCE; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MARKER GENE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH LESION; STOMACH MUCOSA; TISSUE DIFFERENTIATION;

EID: 33748312255     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i31.5033     Document Type: Article

References (30)

1. Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988; 41: 184-197
2. Stoicov C, Saffari R, Cai X, Hasyagar C, Houghton J. Molecular biology of gastric cancer: Helicobacter infection and gastric adenocarcinoma: bacterial and host factors responsible for altered growth signaling. Gene 2004; 341: 1-17
3. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005; 16: 481-488
4. Levi F, La Vecchia C, Lucchini F, Negri E. Cancer mortality in Europe, 1990-92. Eur J Cancer Prev 1995; 4: 389-417
5. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1997; 33: 1075-1107
6. Pinheiro PS, Tyczynski JE, Bray F, Amado J, Matos E, Parkin DM. Cancer incidence and mortality in Portugal. Eur J Cancer 2003; 39: 2507-2520
7. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49
8. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-6740
9. Medeiros R, Morais A, Vasconcelos A, Costa S, Pinto D, Oliveira J, Lopes C. Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer. Eur J Cancer Prev 2002; 11: 343-350
10. Pinto D, Vasconcelos A, Costa S, Pereira D, Rodrigues H, Lopes C, Medeiros R. HER2 polymorphism and breast cancer risk in Portugal. Eur J Cancer Prev 2004; 13: 177-181
11. Catarino R, Matos A, Pinto D, Pereira D, Craveiro R, Vasconcelos A, Lopes C, Medeiros R. Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism. Cancer Genet Cytogenet 2005; 160: 49-54
12. Duarte I, Santos A, Sousa H, Catarino R, Pinto D, Matos A, Pereira D, Moutinho J, Canedo P, Machado JC, Medeiros R. G-308A TNF-alpha polymorphism is associated with an increased risk of invasive cervical cancer. Biochem Biophys Res Commun 2005; 334:588-592
13. Sousa H, Santos AM, Catarino R, Pinto D, Vasconcelos A, Lopes C, Breda E, Medeiros R. Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma development. Eur J Cancer Prev 2006; 15: 362-366
14. Craveiro R, Costa S, Pinto D, Salgado L, Carvalho L, Castro C, Bravo I, Lopes C, Silva I, Medeiros R. TP73 alterations in cervical carcinoma. Cancer Genet Cytogenet 2004; 150: 116-121
15. Medeiros R, Soares R, Vasconcelos A, Schmitt F, Lopes C. Glutathione S-transferase genotype GSTM1 as a predictor of elevated angiogenic phenotype in patients with early onset breast cancer. Angiogenesis 2004; 7: 53-58
16. Ribeiro R, Vasconcelos A, Costa S, Pinto D, Morais A, Oliveira J, Lobo F, Lopes C, Medeiros R. Overexpressing leptin genetic polymorphism (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease. Prostate 2004; 59: 268-274
17. Santos AM, Sousa H, Portela C, Pereira D, Pinto D, Catarino R, Rodrigues C, Araujo AP, Lopes C, Medeiros R. TP53 and P21 polymorphisms: response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer. Biochem Biophys Res Commun 2006; 340: 256-262
18. Vasconcelos A, Medeiros R, Veiga I, Pereira D, Carrilho S, Palmeira C, Azevedo C, Lopes CS. Analysis of estrogen receptor polymorphism in codon 325 by PCR-SSCP in breast cancer: association with lymph node metastasis. Breast J 2002; 8: 226-229
19. Miki K, Ichinose M, Kawamura N, Matsushima M, Ahmad HB, Kimura M, Sano J, Tashiro T, Kakei N, Oka H. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res 1989; 80: 111-114
20. Yamagata Z, Zhang Y, Shinozaki S, Miyamura T, Iijima S, Asaka A, Kobayashi K. Influence of pepsinogen gene polymorphisms on serum pepsinogen. Ann Hum Genet 1997; 61 (Pt 2): 93-97
21. Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, Barbosa J, Guilherme M, Moreira-Dias L, Lomba-Viana H, Silva R, Abreu N, Lomba-Viana R. Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma. Neoplasia 2004; 6: 449-456
22. Ning PF, Liu HJ, Yuan Y. Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases. World J Gastroenterol 2005; 11:2545-2548
23. Taggart RT, Mohandas TK, Bell G. Assignment of the human preprogastricsin (PGC) to chromosome 6 and regional localization of PGC (6pter-p21.1), prolactin PRL (6pter-p21.1). Cytogenet Cell Genet 1987; 46: 701-702
24. Azuma T, Pals G, Taggart RT. RFLP for the human pepsinogen C gene (PGC). Nucleic Acids Res 1988; 16: 9372
25. Taggart RT, Azuma T, Wu S, Bell GI, Bowcock AM. A highly informative polymorphism of the pepsinogen C gene detected by polymerase chain reaction. Adv Exp Med Biol 1991; 306: 95-99
26. Liu HJ, Guo XL, Dong M, Wang L, Yuan Y. Association between pepsinogen C gene polymorphism and genetic predisposition to gastric cancer. World J Gastroenterol 2003; 9: 50-53
27. Mullenbach R, Lagoda PJ, Welter C. An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet 1989; 5: 391
28. Ohtaka Y, Azuma T, Konishi J, Ito S, Kuriyama M. Association between genetic polymorphism. of the pepsinogen C gene and gastric body ulcer: the genetic predisposition is not associated with Helicobacter pylori infection. Gut 1997; 41: 469-474
29. Venkateshwari A, Vidyasagar A, Prasad R, Pratap B, Pratibha N. Pepsinogen polymorphism in the Indian population and its association with duodenal ulcer. Hum Genet 1997; 101: 201-204
30. Wells M, Brown B, Hall J. Pepsinogen C expression in intestinal IEC-6 cells. Cell Physiol Biochem 2003; 13: 301-308